Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,240 | -31,849 | -21,098 | -14,673 | -12,584 |
| Depreciation Amortization | 223 | 227 | 100 | 75 | 52 |
| Accounts receivable | 3,086 | -7,834 | -229 | 412 | 1,885 |
| Accounts payable and accrued liabilities | -67 | -1,190 | -175 | 1,222 | N/A |
| Other Working Capital | 11,576 | -3,931 | -18,403 | 535 | -19,919 |
| Other Operating Activity | -5,886 | 8,650 | -3,688 | -7,834 | 3,726 |
| Operating Cash Flow | $-17,308 | $-35,927 | $-43,493 | $-20,263 | $-26,840 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,448 | 32,679 | -20,897 | 25,147 | -59,058 |
| PPE Investments | -82 | -253 | -291 | -79 | -68 |
| Investing Cash Flow | $5,366 | $32,426 | $-21,188 | $25,068 | $-59,126 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,874 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 22,402 | 10 | 54,239 | 219 | 47,481 |
| Other Financing Activity | -29 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $25,247 | $10 | $54,239 | $219 | $47,481 |
| Exchange Rate Effect | N/A | 9 | N/A | -40 | -33 |
| Beginning Cash Position | 14,593 | 18,075 | 28,517 | 23,533 | 62,051 |
| End Cash Position | 27,897 | 14,593 | 18,075 | 28,517 | 23,533 |
| Net Cash Flow | $13,304 | $-3,482 | $-10,442 | $4,984 | $-38,518 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,308 | -35,927 | -43,493 | -20,263 | -26,840 |
| Capital Expenditure | -82 | -253 | -291 | -79 | -68 |
| Free Cash Flow | -17,390 | -36,180 | -43,784 | -20,342 | -26,908 |